CANINE PARVOVIRUS DNA VACCINES

摘要

This invention relates to the use of a DNA vaccine for the manufacture of a medicament for use in eliciting an immune response against parvovirus in a mater nally derived antibody positive animals. The DNA vaccine comprises a plasmid vector and at lea st one isolated nucleotide sequence encoding a parvovirus immunogenic polypeptide, and transcriptional regulatory sequences operably linked to the isolated nucleotide sequence.